Regenxbio
RGNX
RGNX
89 hedge funds and large institutions have $704M invested in Regenxbio in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
15% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 20
3% more funds holding
Funds holding: 86 → 89 (+3)
4.36% less ownership
Funds ownership: 73.51% → 69.15% (-4.4%)
Holders
89
Holding in Top 10
3
Calls
$2.12M
Puts
$491K
Top Buyers
| 1 | +$13.7M | |
| 2 | +$9.5M | |
| 3 | +$8.77M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$7.42M |
| 5 |
BlackRock
New York
|
+$5.27M |
Top Sellers
| 1 | -$34.2M | |
| 2 | -$10.4M | |
| 3 | -$6.33M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.19M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$5.36M |